 Ross Kedl
Concepts (494)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 63 | 2025 | 917 | 8.160 |
Why?
| | Immunologic Memory | 29 | 2025 | 366 | 4.960 |
Why?
| | Dendritic Cells | 30 | 2022 | 499 | 3.740 |
Why?
| | T-Lymphocytes | 24 | 2024 | 1982 | 2.260 |
Why?
| | Lymphocyte Activation | 27 | 2022 | 1126 | 2.070 |
Why?
| | Vaccines, Subunit | 6 | 2021 | 53 | 1.970 |
Why?
| | Antigen Presentation | 10 | 2017 | 205 | 1.870 |
Why?
| | Interleukins | 9 | 2025 | 248 | 1.730 |
Why?
| | CD40 Antigens | 13 | 2025 | 90 | 1.720 |
Why?
| | Antigens | 10 | 2017 | 347 | 1.630 |
Why?
| | Interleukin-27 | 6 | 2025 | 13 | 1.580 |
Why?
| | Mice, Inbred C57BL | 54 | 2026 | 5997 | 1.540 |
Why?
| | Adjuvants, Immunologic | 15 | 2025 | 245 | 1.470 |
Why?
| | Interleukin-15 | 7 | 2025 | 97 | 1.400 |
Why?
| | Membrane Glycoproteins | 11 | 2014 | 496 | 1.360 |
Why?
| | CD27 Ligand | 4 | 2015 | 9 | 1.350 |
Why?
| | Vaccines | 6 | 2019 | 389 | 1.330 |
Why?
| | T-Lymphocyte Subsets | 8 | 2014 | 415 | 1.280 |
Why?
| | Mice | 81 | 2026 | 18365 | 1.260 |
Why?
| | Interferon Type I | 7 | 2017 | 145 | 1.170 |
Why?
| | Animals | 101 | 2026 | 38109 | 1.160 |
Why?
| | Lymph Nodes | 6 | 2017 | 502 | 1.080 |
Why?
| | CD4-Positive T-Lymphocytes | 15 | 2021 | 1129 | 1.080 |
Why?
| | Mice, Knockout | 28 | 2026 | 3125 | 1.050 |
Why?
| | Listeria monocytogenes | 6 | 2025 | 116 | 1.030 |
Why?
| | CD8 Antigens | 4 | 2019 | 72 | 1.030 |
Why?
| | Mice, Transgenic | 21 | 2021 | 2185 | 0.960 |
Why?
| | Ovalbumin | 14 | 2025 | 190 | 0.960 |
Why?
| | Immunity, Innate | 7 | 2022 | 846 | 0.950 |
Why?
| | Toll-Like Receptor 7 | 10 | 2014 | 43 | 0.910 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 3 | 2015 | 28 | 0.890 |
Why?
| | Interleukin-12 | 8 | 2025 | 117 | 0.890 |
Why?
| | B-Lymphocytes | 5 | 2025 | 877 | 0.870 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 93 | 0.860 |
Why?
| | T-Lymphocytes, Helper-Inducer | 3 | 2021 | 131 | 0.860 |
Why?
| | Emergency Responders | 2 | 2021 | 37 | 0.820 |
Why?
| | Melanoma, Experimental | 6 | 2025 | 108 | 0.770 |
Why?
| | Cross-Priming | 4 | 2011 | 16 | 0.760 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 263 | 0.760 |
Why?
| | Cancer Vaccines | 7 | 2016 | 160 | 0.750 |
Why?
| | Listeriosis | 3 | 2025 | 65 | 0.750 |
Why?
| | Epitopes, T-Lymphocyte | 8 | 2021 | 175 | 0.710 |
Why?
| | Interleukin-2 Receptor beta Subunit | 4 | 2025 | 24 | 0.700 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 37 | 0.670 |
Why?
| | Immunity | 2 | 2019 | 139 | 0.660 |
Why?
| | Cell Differentiation | 13 | 2025 | 2050 | 0.660 |
Why?
| | Signal Transduction | 17 | 2025 | 5233 | 0.650 |
Why?
| | Lymphocyte Depletion | 3 | 2019 | 132 | 0.630 |
Why?
| | Adaptive Immunity | 5 | 2020 | 169 | 0.610 |
Why?
| | Poly I-C | 6 | 2015 | 57 | 0.580 |
Why?
| | Immunity, Cellular | 5 | 2015 | 272 | 0.570 |
Why?
| | Antigens, Viral | 2 | 2014 | 182 | 0.560 |
Why?
| | Interferon-gamma | 4 | 2023 | 784 | 0.550 |
Why?
| | Cell Proliferation | 7 | 2025 | 2499 | 0.550 |
Why?
| | Receptors, Antigen, T-Cell | 9 | 2020 | 668 | 0.530 |
Why?
| | Immunotherapy, Adoptive | 2 | 2025 | 337 | 0.530 |
Why?
| | Adoptive Transfer | 11 | 2020 | 198 | 0.520 |
Why?
| | Toll-Like Receptors | 7 | 2020 | 194 | 0.510 |
Why?
| | Aminoquinolines | 4 | 2005 | 18 | 0.510 |
Why?
| | Vaccination | 9 | 2021 | 1423 | 0.500 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 4 | 2025 | 42 | 0.490 |
Why?
| | Receptors, Cell Surface | 5 | 2005 | 377 | 0.480 |
Why?
| | Bystander Effect | 1 | 2016 | 19 | 0.480 |
Why?
| | Receptor, Interferon alpha-beta | 3 | 2017 | 35 | 0.470 |
Why?
| | Toxoplasmosis | 3 | 2025 | 43 | 0.470 |
Why?
| | Endothelium, Lymphatic | 1 | 2015 | 11 | 0.460 |
Why?
| | Cell Movement | 8 | 2022 | 965 | 0.460 |
Why?
| | Cytotoxicity, Immunologic | 7 | 2025 | 223 | 0.450 |
Why?
| | Squalene | 1 | 2015 | 8 | 0.450 |
Why?
| | H-2 Antigens | 5 | 2016 | 111 | 0.440 |
Why?
| | Antigens, Neoplasm | 5 | 2018 | 272 | 0.440 |
Why?
| | Breeding | 1 | 2014 | 63 | 0.430 |
Why?
| | Caspase 1 | 1 | 2015 | 148 | 0.420 |
Why?
| | Housing, Animal | 1 | 2014 | 46 | 0.420 |
Why?
| | Bacterial Vaccines | 1 | 2014 | 63 | 0.420 |
Why?
| | OX40 Ligand | 2 | 2011 | 10 | 0.420 |
Why?
| | Immunization | 9 | 2020 | 374 | 0.410 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2023 | 292 | 0.410 |
Why?
| | Caspases | 1 | 2015 | 232 | 0.410 |
Why?
| | Viral Vaccines | 2 | 2014 | 107 | 0.400 |
Why?
| | Interleukin-18 | 1 | 2015 | 235 | 0.400 |
Why?
| | Repressor Proteins | 4 | 2025 | 437 | 0.390 |
Why?
| | Cytokines | 13 | 2019 | 2065 | 0.390 |
Why?
| | Cell Lineage | 3 | 2013 | 376 | 0.380 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 276 | 0.380 |
Why?
| | Receptors, OX40 | 1 | 2011 | 15 | 0.360 |
Why?
| | Tumor Necrosis Factors | 1 | 2011 | 10 | 0.360 |
Why?
| | Up-Regulation | 5 | 2022 | 852 | 0.360 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 130 | 0.360 |
Why?
| | T-Cell Antigen Receptor Specificity | 4 | 2016 | 45 | 0.350 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2026 | 233 | 0.350 |
Why?
| | Chemokines | 4 | 2020 | 218 | 0.350 |
Why?
| | Spleen | 8 | 2019 | 508 | 0.350 |
Why?
| | Virus Diseases | 1 | 2014 | 216 | 0.350 |
Why?
| | Antibodies, Viral | 6 | 2023 | 672 | 0.350 |
Why?
| | Immunity, Humoral | 3 | 2023 | 120 | 0.350 |
Why?
| | Vaccinia | 3 | 2018 | 20 | 0.350 |
Why?
| | Cells, Cultured | 11 | 2019 | 4155 | 0.340 |
Why?
| | Endothelial Cells | 1 | 2017 | 870 | 0.340 |
Why?
| | Vaccines, Conjugate | 2 | 2010 | 60 | 0.340 |
Why?
| | Orthomyxoviridae Infections | 3 | 2021 | 72 | 0.330 |
Why?
| | Antigen-Presenting Cells | 5 | 2018 | 160 | 0.320 |
Why?
| | Homeostasis | 3 | 2025 | 640 | 0.320 |
Why?
| | Humans | 46 | 2026 | 144957 | 0.310 |
Why?
| | Female | 39 | 2025 | 78376 | 0.300 |
Why?
| | Pancreatic Neoplasms | 3 | 2023 | 927 | 0.300 |
Why?
| | Toxoplasma | 3 | 2025 | 49 | 0.290 |
Why?
| | Industry | 1 | 2009 | 43 | 0.290 |
Why?
| | Th1 Cells | 5 | 2019 | 139 | 0.290 |
Why?
| | Career Mobility | 1 | 2009 | 72 | 0.280 |
Why?
| | T-Lymphocytes, Regulatory | 4 | 2025 | 389 | 0.280 |
Why?
| | Lymphocyte Count | 4 | 2021 | 164 | 0.270 |
Why?
| | Forkhead Box Protein O1 | 2 | 2025 | 36 | 0.250 |
Why?
| | Myeloid Cells | 4 | 2021 | 148 | 0.250 |
Why?
| | Monocytes | 5 | 2025 | 538 | 0.250 |
Why?
| | Skin Neoplasms | 2 | 2022 | 847 | 0.250 |
Why?
| | Career Choice | 1 | 2009 | 237 | 0.250 |
Why?
| | Chemokine CXCL10 | 3 | 2025 | 39 | 0.250 |
Why?
| | Radiation Chimera | 3 | 2014 | 27 | 0.240 |
Why?
| | Universities | 1 | 2009 | 452 | 0.240 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2006 | 66 | 0.240 |
Why?
| | Receptors, Lipoprotein | 1 | 2026 | 16 | 0.240 |
Why?
| | Receptors, CXCR3 | 2 | 2025 | 17 | 0.240 |
Why?
| | Oligopeptides | 2 | 2012 | 269 | 0.240 |
Why?
| | Viral Proteins | 2 | 2001 | 355 | 0.230 |
Why?
| | Binding, Competitive | 2 | 2003 | 193 | 0.230 |
Why?
| | Intestinal Absorption | 1 | 2026 | 103 | 0.230 |
Why?
| | Neoplasm Transplantation | 3 | 2006 | 252 | 0.230 |
Why?
| | CD11b Antigen | 2 | 2014 | 60 | 0.220 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 46 | 0.220 |
Why?
| | Mice, 129 Strain | 2 | 2017 | 86 | 0.220 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 40 | 0.220 |
Why?
| | CD11c Antigen | 2 | 2008 | 40 | 0.210 |
Why?
| | Interleukin-2 | 7 | 2025 | 437 | 0.210 |
Why?
| | Mice, Inbred BALB C | 10 | 2020 | 1253 | 0.210 |
Why?
| | Seroepidemiologic Studies | 2 | 2021 | 172 | 0.200 |
Why?
| | Dietary Fats | 1 | 2026 | 315 | 0.200 |
Why?
| | Influenza A virus | 2 | 2021 | 113 | 0.200 |
Why?
| | B7-H1 Antigen | 4 | 2021 | 241 | 0.200 |
Why?
| | Immunophenotyping | 3 | 2019 | 322 | 0.200 |
Why?
| | Peptide Fragments | 4 | 2016 | 699 | 0.190 |
Why?
| | Nanoparticles | 2 | 2025 | 520 | 0.190 |
Why?
| | Influenza Vaccines | 3 | 2025 | 529 | 0.190 |
Why?
| | Cell Adhesion Molecules | 2 | 2022 | 178 | 0.190 |
Why?
| | Omentum | 1 | 2022 | 9 | 0.190 |
Why?
| | Egg Proteins | 2 | 2001 | 20 | 0.190 |
Why?
| | Graft Rejection | 2 | 2017 | 540 | 0.190 |
Why?
| | Hematopoietic Stem Cells | 1 | 2025 | 420 | 0.180 |
Why?
| | Sentinel Lymph Node | 1 | 2022 | 49 | 0.180 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 479 | 0.180 |
Why?
| | Gene Expression | 3 | 2016 | 1490 | 0.180 |
Why?
| | Imidazoles | 5 | 2014 | 254 | 0.180 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 16 | 0.180 |
Why?
| | Chemokine CXCL9 | 1 | 2022 | 38 | 0.180 |
Why?
| | Transcription Factors | 4 | 2023 | 1742 | 0.180 |
Why?
| | Lung | 6 | 2021 | 4109 | 0.180 |
Why?
| | Microspheres | 2 | 2021 | 142 | 0.170 |
Why?
| | Immunotherapy | 5 | 2023 | 657 | 0.170 |
Why?
| | Portraits as Topic | 1 | 2021 | 1 | 0.170 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2022 | 1462 | 0.170 |
Why?
| | Microfilament Proteins | 1 | 2022 | 136 | 0.170 |
Why?
| | Male | 22 | 2026 | 72406 | 0.170 |
Why?
| | Receptors, CCR2 | 1 | 2021 | 39 | 0.170 |
Why?
| | Immunoglobulin M | 2 | 2022 | 284 | 0.170 |
Why?
| | Mutation | 2 | 2025 | 4099 | 0.170 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4569 | 0.170 |
Why?
| | Receptors, Virus | 1 | 2021 | 96 | 0.170 |
Why?
| | Immunologic Factors | 1 | 2003 | 255 | 0.170 |
Why?
| | RNA, Messenger | 4 | 2025 | 2832 | 0.170 |
Why?
| | Luminescent Proteins | 1 | 2001 | 185 | 0.160 |
Why?
| | Immunoassay | 1 | 2021 | 109 | 0.160 |
Why?
| | Immunity, Mucosal | 1 | 2021 | 98 | 0.160 |
Why?
| | Transcriptional Activation | 2 | 2022 | 383 | 0.160 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2005 | 1217 | 0.160 |
Why?
| | Lipids | 1 | 2025 | 710 | 0.160 |
Why?
| | Specimen Handling | 1 | 2022 | 186 | 0.160 |
Why?
| | Cell Communication | 4 | 2013 | 324 | 0.150 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 330 | 0.150 |
Why?
| | Primary Cell Culture | 2 | 2021 | 174 | 0.150 |
Why?
| | Actins | 1 | 2022 | 425 | 0.150 |
Why?
| | Phosphoproteins | 1 | 2022 | 346 | 0.150 |
Why?
| | Integrin alpha Chains | 3 | 2019 | 22 | 0.150 |
Why?
| | Glycoproteins | 1 | 2001 | 355 | 0.150 |
Why?
| | Macrophages | 2 | 2021 | 1511 | 0.150 |
Why?
| | Disease Resistance | 1 | 2019 | 29 | 0.150 |
Why?
| | Liposomes | 5 | 2025 | 250 | 0.150 |
Why?
| | Allergens | 2 | 2021 | 384 | 0.150 |
Why?
| | Costimulatory and Inhibitory T-Cell Receptors | 1 | 2019 | 7 | 0.150 |
Why?
| | Joints | 1 | 2020 | 107 | 0.150 |
Why?
| | Chikungunya Fever | 1 | 2020 | 84 | 0.150 |
Why?
| | Chikungunya virus | 1 | 2020 | 86 | 0.140 |
Why?
| | Aerobiosis | 1 | 2018 | 22 | 0.140 |
Why?
| | T-Box Domain Proteins | 1 | 2019 | 106 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2021 | 252 | 0.140 |
Why?
| | Flow Cytometry | 5 | 2016 | 1173 | 0.140 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2021 | 199 | 0.140 |
Why?
| | Immune Tolerance | 3 | 2012 | 379 | 0.140 |
Why?
| | Mitochondria | 1 | 2025 | 984 | 0.140 |
Why?
| | Antibodies, Monoclonal | 4 | 2019 | 1524 | 0.140 |
Why?
| | Multiple Sclerosis | 1 | 2024 | 484 | 0.140 |
Why?
| | Gene Expression Regulation | 6 | 2013 | 2609 | 0.140 |
Why?
| | Peptides | 5 | 2013 | 998 | 0.140 |
Why?
| | Vaccines, DNA | 2 | 2009 | 31 | 0.140 |
Why?
| | Cell Membrane | 1 | 2001 | 706 | 0.140 |
Why?
| | Vaccinia virus | 3 | 2010 | 34 | 0.130 |
Why?
| | Lymphocytes | 2 | 2022 | 382 | 0.130 |
Why?
| | Autoimmunity | 3 | 2025 | 927 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 562 | 0.130 |
Why?
| | Interleukin-10 | 1 | 2019 | 310 | 0.130 |
Why?
| | Gene Products, gag | 3 | 2006 | 38 | 0.130 |
Why?
| | Killer Cells, Natural | 2 | 2019 | 469 | 0.130 |
Why?
| | Antigens, CD | 4 | 2019 | 555 | 0.130 |
Why?
| | Friend murine leukemia virus | 1 | 2017 | 31 | 0.130 |
Why?
| | Transplantation Tolerance | 1 | 2017 | 37 | 0.130 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2018 | 168 | 0.130 |
Why?
| | Cytidine Deaminase | 1 | 2017 | 59 | 0.120 |
Why?
| | Glycolysis | 1 | 2018 | 340 | 0.120 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2017 | 67 | 0.120 |
Why?
| | Melanoma | 2 | 2022 | 761 | 0.120 |
Why?
| | Antibodies | 3 | 2015 | 403 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 2 | 2016 | 331 | 0.110 |
Why?
| | Epitopes | 3 | 2007 | 485 | 0.110 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2016 | 163 | 0.110 |
Why?
| | Myeloid Differentiation Factor 88 | 3 | 2011 | 116 | 0.110 |
Why?
| | Caspases, Initiator | 1 | 2015 | 17 | 0.110 |
Why?
| | AIDS Vaccines | 2 | 2005 | 52 | 0.110 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2018 | 216 | 0.110 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2015 | 47 | 0.110 |
Why?
| | Antibody Formation | 2 | 2013 | 294 | 0.110 |
Why?
| | DNA-Binding Proteins | 2 | 2018 | 1500 | 0.110 |
Why?
| | Neoplasm Proteins | 1 | 2018 | 444 | 0.110 |
Why?
| | Host-Pathogen Interactions | 1 | 2018 | 371 | 0.110 |
Why?
| | Immunoglobulin G | 5 | 2022 | 893 | 0.110 |
Why?
| | Reoviridae | 1 | 1995 | 38 | 0.110 |
Why?
| | Toll-Like Receptor 9 | 2 | 2006 | 37 | 0.110 |
Why?
| | Skin Transplantation | 1 | 2015 | 85 | 0.110 |
Why?
| | Coculture Techniques | 1 | 2015 | 246 | 0.110 |
Why?
| | Smallpox Vaccine | 1 | 2014 | 23 | 0.110 |
Why?
| | Receptors, Cytokine | 1 | 2014 | 36 | 0.110 |
Why?
| | Receptors, Interleukin | 1 | 2014 | 43 | 0.110 |
Why?
| | Adenocarcinoma | 1 | 2022 | 931 | 0.110 |
Why?
| | STAT Transcription Factors | 1 | 2014 | 24 | 0.110 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2014 | 76 | 0.110 |
Why?
| | Tumor Cells, Cultured | 3 | 2021 | 919 | 0.110 |
Why?
| | Pandemics | 1 | 2023 | 1695 | 0.100 |
Why?
| | Antibodies, Neutralizing | 1 | 2017 | 341 | 0.100 |
Why?
| | Protein Binding | 3 | 2025 | 2276 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1995 | 396 | 0.100 |
Why?
| | Capsid Proteins | 1 | 1995 | 95 | 0.100 |
Why?
| | Colorado | 2 | 2021 | 4564 | 0.100 |
Why?
| | Virus Replication | 1 | 2017 | 529 | 0.100 |
Why?
| | Leukocytes, Mononuclear | 3 | 2013 | 573 | 0.100 |
Why?
| | Gangliosides | 1 | 2013 | 23 | 0.100 |
Why?
| | Growth Hormone | 1 | 2013 | 92 | 0.100 |
Why?
| | Proto-Oncogene Proteins pp60(c-src) | 1 | 2013 | 14 | 0.100 |
Why?
| | Autoantigens | 1 | 2016 | 429 | 0.100 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2013 | 17 | 0.100 |
Why?
| | Genes, MHC Class II | 1 | 2013 | 76 | 0.100 |
Why?
| | Phenotype | 2 | 2019 | 3164 | 0.100 |
Why?
| | Transplantation Chimera | 1 | 2013 | 56 | 0.100 |
Why?
| | Clone Cells | 4 | 2001 | 266 | 0.090 |
Why?
| | Whole-Body Irradiation | 1 | 2013 | 76 | 0.090 |
Why?
| | Guidelines as Topic | 1 | 2014 | 268 | 0.090 |
Why?
| | Muramidase | 1 | 2012 | 67 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2012 | 100 | 0.090 |
Why?
| | Obesity | 1 | 2026 | 3082 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2007 | 364 | 0.090 |
Why?
| | Recombinant Proteins | 2 | 2013 | 1371 | 0.090 |
Why?
| | Antigenic Variation | 1 | 2011 | 11 | 0.090 |
Why?
| | Moloney murine leukemia virus | 1 | 2011 | 13 | 0.090 |
Why?
| | Receptors, Interleukin-12 | 1 | 2011 | 6 | 0.090 |
Why?
| | Thymus Gland | 1 | 2013 | 311 | 0.090 |
Why?
| | Toll-Like Receptor 3 | 2 | 2014 | 28 | 0.090 |
Why?
| | Myocarditis | 1 | 2012 | 102 | 0.090 |
Why?
| | Transplantation, Homologous | 3 | 2017 | 415 | 0.080 |
Why?
| | Immunoglobulin E | 1 | 2012 | 315 | 0.080 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3550 | 0.080 |
Why?
| | Viral Envelope Proteins | 1 | 2011 | 98 | 0.080 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 464 | 0.080 |
Why?
| | Nasal Mucosa | 1 | 2011 | 112 | 0.080 |
Why?
| | Hyaluronan Receptors | 2 | 2009 | 102 | 0.080 |
Why?
| | Body Weight | 1 | 2014 | 978 | 0.080 |
Why?
| | Nucleic Acids | 1 | 2011 | 72 | 0.080 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2022 | 154 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 906 | 0.080 |
Why?
| | Time Factors | 1 | 2021 | 7183 | 0.080 |
Why?
| | Macaca mulatta | 3 | 2019 | 191 | 0.080 |
Why?
| | Granzymes | 2 | 2022 | 49 | 0.080 |
Why?
| | Polyethyleneimine | 1 | 2009 | 18 | 0.080 |
Why?
| | Toll-Like Receptor 5 | 1 | 2009 | 18 | 0.080 |
Why?
| | Organ Specificity | 2 | 2001 | 313 | 0.070 |
Why?
| | Toll-Like Receptor 8 | 2 | 2006 | 8 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2456 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 2016 | 2157 | 0.070 |
Why?
| | Liver | 2 | 2016 | 1888 | 0.070 |
Why?
| | Injections, Intravenous | 2 | 2013 | 200 | 0.070 |
Why?
| | Bronchial Hyperreactivity | 1 | 2009 | 96 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 1 | 2012 | 475 | 0.070 |
Why?
| | Proto-Oncogene Proteins | 2 | 2002 | 623 | 0.070 |
Why?
| | Lectins, C-Type | 2 | 2020 | 62 | 0.070 |
Why?
| | Kupffer Cells | 1 | 2008 | 53 | 0.070 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 463 | 0.070 |
Why?
| | Baculoviridae | 1 | 2008 | 44 | 0.070 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1496 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2012 | 780 | 0.070 |
Why?
| | Insecta | 1 | 2008 | 74 | 0.070 |
Why?
| | B7-1 Antigen | 3 | 2009 | 55 | 0.070 |
Why?
| | Interferon Inducers | 2 | 2008 | 8 | 0.060 |
Why?
| | Major Histocompatibility Complex | 2 | 2008 | 229 | 0.060 |
Why?
| | Saccharomyces cerevisiae | 1 | 2012 | 579 | 0.060 |
Why?
| | Research Personnel | 1 | 2009 | 186 | 0.060 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 635 | 0.060 |
Why?
| | Tumor Microenvironment | 2 | 2022 | 735 | 0.060 |
Why?
| | Histocompatibility Antigen H-2D | 2 | 2008 | 20 | 0.060 |
Why?
| | Ligands | 2 | 2025 | 674 | 0.060 |
Why?
| | Injections, Intradermal | 1 | 2006 | 11 | 0.060 |
Why?
| | Oleic Acids | 1 | 2006 | 12 | 0.060 |
Why?
| | Chylomicrons | 1 | 2026 | 19 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2009 | 509 | 0.060 |
Why?
| | Mannitol | 1 | 2006 | 40 | 0.060 |
Why?
| | Injections, Intraperitoneal | 2 | 2013 | 117 | 0.060 |
Why?
| | Immunosuppressive Agents | 2 | 2009 | 847 | 0.060 |
Why?
| | T-Lymphocytes, Cytotoxic | 2 | 2022 | 177 | 0.060 |
Why?
| | HIV Antigens | 1 | 2005 | 17 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 923 | 0.060 |
Why?
| | Lipoproteins, HDL | 1 | 2026 | 101 | 0.060 |
Why?
| | Neoplasms, Experimental | 1 | 2006 | 173 | 0.060 |
Why?
| | Oligodeoxyribonucleotides | 4 | 2006 | 141 | 0.060 |
Why?
| | STAT5 Transcription Factor | 1 | 2025 | 52 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2642 | 0.060 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2025 | 45 | 0.050 |
Why?
| | Intestine, Small | 1 | 2026 | 166 | 0.050 |
Why?
| | Cell Adhesion | 1 | 2006 | 455 | 0.050 |
Why?
| | CD40 Ligand | 2 | 2018 | 40 | 0.050 |
Why?
| | Genes, Reporter | 2 | 2002 | 276 | 0.050 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2004 | 37 | 0.050 |
Why?
| | Transfection | 3 | 2019 | 940 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 866 | 0.050 |
Why?
| | Asthma | 2 | 2012 | 1768 | 0.050 |
Why?
| | Ovarian Neoplasms | 1 | 2009 | 586 | 0.050 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2023 | 80 | 0.050 |
Why?
| | Genes, bcl-2 | 1 | 2002 | 22 | 0.050 |
Why?
| | 4-Butyrolactone | 1 | 2022 | 23 | 0.050 |
Why?
| | Apoptosis | 1 | 2011 | 2430 | 0.050 |
Why?
| | Neoplasms | 2 | 2009 | 2884 | 0.050 |
Why?
| | Leukemia | 1 | 2025 | 245 | 0.050 |
Why?
| | Ubiquitin C | 1 | 2001 | 3 | 0.050 |
Why?
| | Interphase | 2 | 1999 | 38 | 0.040 |
Why?
| | THP-1 Cells | 1 | 2021 | 20 | 0.040 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 156 | 0.040 |
Why?
| | World Health Organization | 1 | 2022 | 105 | 0.040 |
Why?
| | CTLA-4 Antigen | 2 | 2019 | 104 | 0.040 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2001 | 113 | 0.040 |
Why?
| | Polymerization | 1 | 2022 | 130 | 0.040 |
Why?
| | Lymph Node Excision | 1 | 2022 | 173 | 0.040 |
Why?
| | Pregnancy | 1 | 2014 | 7191 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2001 | 758 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 241 | 0.040 |
Why?
| | Macromolecular Substances | 1 | 2001 | 224 | 0.040 |
Why?
| | Cell Line | 2 | 2005 | 2882 | 0.040 |
Why?
| | Transcriptome | 2 | 2019 | 1046 | 0.040 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 264 | 0.040 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2020 | 16 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 322 | 0.040 |
Why?
| | Acrylic Resins | 1 | 2020 | 45 | 0.040 |
Why?
| | Receptors, Mitogen | 1 | 2020 | 7 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2021 | 191 | 0.040 |
Why?
| | Drosophila Proteins | 1 | 2002 | 212 | 0.040 |
Why?
| | STAT3 Transcription Factor | 1 | 2022 | 207 | 0.040 |
Why?
| | Keratinocytes | 1 | 2021 | 250 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2001 | 405 | 0.040 |
Why?
| | Middle Aged | 3 | 2021 | 35928 | 0.040 |
Why?
| | Mice, Inbred Strains | 1 | 2000 | 397 | 0.040 |
Why?
| | RNA, Viral | 1 | 2024 | 688 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 348 | 0.040 |
Why?
| | Lipopolysaccharides | 4 | 2006 | 863 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2022 | 1268 | 0.040 |
Why?
| | Gene Expression Profiling | 3 | 2002 | 1786 | 0.040 |
Why?
| | Arthritis | 1 | 2020 | 96 | 0.040 |
Why?
| | Clonal Anergy | 1 | 1999 | 54 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2019 | 54 | 0.040 |
Why?
| | HIV-1 | 1 | 2005 | 896 | 0.040 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 1999 | 138 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2001 | 675 | 0.040 |
Why?
| | Homozygote | 1 | 2019 | 199 | 0.040 |
Why?
| | Aged | 2 | 2016 | 25947 | 0.030 |
Why?
| | Survival Analysis | 1 | 2022 | 1385 | 0.030 |
Why?
| | Siblings | 1 | 2019 | 195 | 0.030 |
Why?
| | Plasmids | 2 | 2011 | 379 | 0.030 |
Why?
| | Cations | 2 | 2009 | 82 | 0.030 |
Why?
| | Receptors, Immunologic | 1 | 2019 | 206 | 0.030 |
Why?
| | Genome | 1 | 2000 | 306 | 0.030 |
Why?
| | Immunoconjugates | 1 | 1999 | 137 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 1031 | 0.030 |
Why?
| | Cytomegalovirus Infections | 1 | 2019 | 206 | 0.030 |
Why?
| | Promoter Regions, Genetic | 1 | 2001 | 1258 | 0.030 |
Why?
| | Adult | 2 | 2021 | 40506 | 0.030 |
Why?
| | Cell Separation | 2 | 2012 | 307 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 42 | 0.030 |
Why?
| | Arenaviridae Infections | 1 | 2016 | 17 | 0.030 |
Why?
| | Biomarkers | 2 | 2021 | 4275 | 0.030 |
Why?
| | Skin | 1 | 2021 | 758 | 0.030 |
Why?
| | Lymphocytic choriomeningitis virus | 1 | 2016 | 36 | 0.030 |
Why?
| | Carboxymethylcellulose Sodium | 1 | 2015 | 5 | 0.030 |
Why?
| | Polylysine | 1 | 2015 | 17 | 0.030 |
Why?
| | CpG Islands | 2 | 2006 | 165 | 0.030 |
Why?
| | Histocompatibility Testing | 1 | 2015 | 121 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2001 | 2931 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1813 | 0.030 |
Why?
| | Down-Regulation | 2 | 2011 | 627 | 0.030 |
Why?
| | Hypodermoclysis | 1 | 2013 | 4 | 0.030 |
Why?
| | Disease Progression | 1 | 2022 | 2852 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 226 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2020 | 768 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1619 | 0.030 |
Why?
| | Stem Cells | 1 | 1998 | 627 | 0.030 |
Why?
| | Species Specificity | 1 | 1995 | 574 | 0.020 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2013 | 109 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1054 | 0.020 |
Why?
| | Immunological Synapses | 1 | 2012 | 16 | 0.020 |
Why?
| | Interleukin-1 | 2 | 2012 | 961 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2012 | 103 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2015 | 636 | 0.020 |
Why?
| | Interferon-alpha | 2 | 2005 | 197 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2015 | 322 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 341 | 0.020 |
Why?
| | Particle Size | 1 | 2013 | 411 | 0.020 |
Why?
| | Cattle | 1 | 1995 | 1000 | 0.020 |
Why?
| | Clodronic Acid | 1 | 2012 | 19 | 0.020 |
Why?
| | Chemokine CXCL1 | 1 | 2012 | 76 | 0.020 |
Why?
| | Inflammation | 2 | 2020 | 2880 | 0.020 |
Why?
| | Diphtheria Toxin | 1 | 2012 | 65 | 0.020 |
Why?
| | Aerosols | 1 | 2012 | 186 | 0.020 |
Why?
| | Chemokine CCL2 | 1 | 2012 | 116 | 0.020 |
Why?
| | Melioidosis | 1 | 2011 | 5 | 0.020 |
Why?
| | Burkholderia pseudomallei | 1 | 2011 | 10 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 575 | 0.020 |
Why?
| | Bone Marrow | 1 | 2013 | 306 | 0.020 |
Why?
| | Administration, Intranasal | 1 | 2011 | 93 | 0.020 |
Why?
| | Models, Animal | 1 | 2013 | 392 | 0.020 |
Why?
| | Th17 Cells | 1 | 2012 | 101 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 161 | 0.020 |
Why?
| | Lipoproteins | 1 | 2012 | 169 | 0.020 |
Why?
| | Pulmonary Emphysema | 1 | 2013 | 275 | 0.020 |
Why?
| | Cysteine | 1 | 2012 | 210 | 0.020 |
Why?
| | Phylogeny | 1 | 1995 | 1019 | 0.020 |
Why?
| | Weight Gain | 1 | 2013 | 559 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2012 | 395 | 0.020 |
Why?
| | Methacholine Chloride | 1 | 2009 | 50 | 0.020 |
Why?
| | Echocardiography | 1 | 2012 | 652 | 0.020 |
Why?
| | Prostaglandin D2 | 1 | 2008 | 22 | 0.020 |
Why?
| | Ischemia | 1 | 2012 | 421 | 0.020 |
Why?
| | Cell Death | 2 | 2001 | 383 | 0.020 |
Why?
| | Heart | 1 | 2012 | 636 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2009 | 139 | 0.020 |
Why?
| | Cell Transplantation | 1 | 2008 | 39 | 0.020 |
Why?
| | Dinoprostone | 1 | 2008 | 178 | 0.020 |
Why?
| | Metabolomics | 1 | 2013 | 727 | 0.020 |
Why?
| | Cell Survival | 2 | 2002 | 1098 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 299 | 0.020 |
Why?
| | Zymosan | 1 | 2006 | 39 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10792 | 0.020 |
Why?
| | Nucleocapsid Proteins | 1 | 2005 | 28 | 0.010 |
Why?
| | Age Factors | 1 | 2013 | 3335 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2008 | 695 | 0.010 |
Why?
| | Primates | 1 | 2005 | 132 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2019 | 11695 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5614 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2008 | 897 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2006 | 428 | 0.010 |
Why?
| | bcl-X Protein | 1 | 2002 | 45 | 0.010 |
Why?
| | Superantigens | 1 | 2002 | 70 | 0.010 |
Why?
| | Interleukin-3 | 1 | 2002 | 23 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 2006 | 337 | 0.010 |
Why?
| | Receptors, CCR7 | 1 | 2002 | 31 | 0.010 |
Why?
| | Models, Immunological | 1 | 2002 | 100 | 0.010 |
Why?
| | Receptors, Chemokine | 1 | 2002 | 47 | 0.010 |
Why?
| | Chemokines, CXC | 1 | 2002 | 68 | 0.010 |
Why?
| | Genetic Variation | 1 | 2007 | 984 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 766 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 8279 | 0.010 |
Why?
| | Aging | 1 | 2011 | 1966 | 0.010 |
Why?
| | Phorbol Esters | 1 | 2000 | 13 | 0.010 |
Why?
| | Expressed Sequence Tags | 1 | 2000 | 43 | 0.010 |
Why?
| | Jurkat Cells | 1 | 2000 | 114 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1999 | 187 | 0.010 |
Why?
| | Abatacept | 1 | 1999 | 56 | 0.010 |
Why?
| | Antigens, Differentiation | 1 | 1999 | 77 | 0.010 |
Why?
| | Hybridomas | 1 | 1999 | 234 | 0.010 |
Why?
| | Immunization, Secondary | 1 | 1999 | 91 | 0.010 |
Why?
| | Antioxidants | 1 | 2002 | 549 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 662 | 0.010 |
Why?
| | Hot Temperature | 1 | 2000 | 407 | 0.010 |
Why?
| | Databases, Factual | 1 | 2000 | 1486 | 0.010 |
Why?
|
|
Kedl's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|